BioSpace News Archive

BioMidwest

Medtronic, DaVita launch Mozarc Medical, aimed at introducing new solutions for patients with kidney failure

Medtronic plc and DaVita Inc. announced the launch of Mozarc Medical—an independent new company committed to reshaping kidney health and driving patient-centered technology solutions.

April 1, 2023
·
5 min read
REGiMMUNE Limited Licenses the Rights to Develop and Commercialize RGI-2001 To San Fu Biotech in Major Asian Countries

REGiMMUNE Limited, a biotech company focused on creating innovative immunotherapies for immune disorders and cancer, and San Fu Biotech, a subsidiary of San Fu Chemical Co., Ltd. have entered a licensing agreement to develop and commercialize RGI-2001 for the prophylaxis of acute Graft-versus-host disease in major Asian countries.

April 1, 2023
·
4 min read
Drug Development

Travere Therapeutics Announces Interim Analysis from the Phase 3 PROTECT Study of FILSPARI™ (Sparsentan) in IgA Nephropathy Published in The Lancet and Presented at World Congress of Nephrology 2023

Travere Therapeutics, Inc. announced publication in The Lancet of the interim analysis of efficacy and safety data from the ongoing pivotal, Phase 3 PROTECT Study evaluating FILSPARI™ in adults with IgA nephropathy.

April 1, 2023
·
16 min read